CALIWAY BIOPHARMACEUTICALS CO LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of 6919 for the last quarter is 23.26 M TWD, and it's 196.34% higher compared to the previous quarter. The net income of Q3 24 is -137.57 M TWD.